Cook Medical Inc. fielded CMS questions regarding two vascular devices for which the firm is seeking Medicare new-technology add-on payments during a Feb. 14 “town hall” meeting at CMS headquarters in Baltimore.
The Medicare agency is weighing evidence in support of add-on payments in fiscal 2013 for Cook’s Zilver PTX drug-eluting peripheral stent to treat symptomatic vascular disease in above-the-knee femoropopliteal arteries,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?